PNLIP and obesity due to melanocortin 4 receptor deficiency: It can be extrapolated that POCU1b may act as an anti-obesity agent by inhibiting pancreatic lipase and mediating cAMP-dependent PDE inhibition, leading to reduced perilipin and ADRP levels.